These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9443125)

  • 1. Pancreatic enzyme supplementation in cystic fibrosis patients before and after fibrosing colonopathy.
    Stevens JC; Maguiness KM; Hollingsworth J; Heilman DK; Chong SK
    J Pediatr Gastroenterol Nutr; 1998 Jan; 26(1):80-4. PubMed ID: 9443125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis.
    FitzSimmons SC; Burkhart GA; Borowitz D; Grand RJ; Hammerstrom T; Durie PR; Lloyd-Still JD; Lowenfels AB
    N Engl J Med; 1997 May; 336(18):1283-9. PubMed ID: 9113931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing colonopathy in children with cystic fibrosis.
    Reichard KW; Vinocur CD; Franco M; Crisci KL; Flick JA; Billmire DF; Schidlow DV; Weintraub WH
    J Pediatr Surg; 1997 Feb; 32(2):237-41; discussion 241-2. PubMed ID: 9044129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee.
    Borowitz DS; Grand RJ; Durie PR
    J Pediatr; 1995 Nov; 127(5):681-4. PubMed ID: 7472816
    [No Abstract]   [Full Text] [Related]  

  • 5. Is fibrosing colonopathy an immune mediated disease?
    Lee J; Ip W; Durie P
    Arch Dis Child; 1997 Jul; 77(1):66-70. PubMed ID: 9279159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast enema findings of fibrosing colonopathy.
    Crisci KL; Greenberg SB; Wolfson BJ; Geller E; Vinocur CD
    Pediatr Radiol; 1997 Apr; 27(4):315-6. PubMed ID: 9094236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes.
    Waters BL
    Pediatr Dev Pathol; 1998; 1(1):74-8. PubMed ID: 10463274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis-associated colitis and fibrosing colonopathy.
    Schwarzenberg SJ; Wielinski CL; Shamieh I; Carpenter BL; Jessurun J; Weisdorf SA; Warwick WJ; Sharp HL
    J Pediatr; 1995 Oct; 127(4):565-70. PubMed ID: 7562277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic enzyme replacement therapy dosing and nutritional outcomes in children with cystic fibrosis.
    Haupt ME; Kwasny MJ; Schechter MS; McColley SA
    J Pediatr; 2014 May; 164(5):1110-1115.e1. PubMed ID: 24560182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrosing colonopathy in an adult cystic fibrosis patient after discontinuing pancreatic enzyme therapy.
    Mack EH; Brett AS; Brown D
    South Med J; 2004 Sep; 97(9):901-4. PubMed ID: 15455984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA
    Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D; Ball LM; Dezfulian AR; Southgate A; Howard CV
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis.
    Franzen D; Went P; Buhlmann U
    Indian J Gastroenterol; 2008; 27(3):133-4. PubMed ID: 18787288
    [No Abstract]   [Full Text] [Related]  

  • 14. Colonic strictures in patients with cystic fibrosis: results of a survey of 114 cystic fibrosis care centers in the United States.
    Freiman JP; FitzSimmons SC
    J Pediatr Gastroenterol Nutr; 1996 Feb; 22(2):153-6. PubMed ID: 8642487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis.
    Littlewood JM; Wolfe SP; Conway SP
    Pediatr Pulmonol; 2006 Jan; 41(1):35-49. PubMed ID: 16288483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosing colonopathy in an adult caused by over use of pancreatic enzyme supplements.
    Häusler M; Heimann G; Meilcke R; Biesterfeld S
    Gut; 2000 Oct; 47(4):598. PubMed ID: 11203308
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and preliminary clinical activity of a novel pancreatic enzyme preparation in pancreatic insufficient cystic fibrosis patients.
    Borowitz D; Goss CH; Stevens C; Hayes D; Newman L; O'Rourke A; Konstan MW; Wagener J; Moss R; Hendeles L; Orenstein D; Ahrens R; Oermann CM; Aitken ML; Mahl TC; Young KR; Dunitz J; Murray FT
    Pancreas; 2006 Apr; 32(3):258-63. PubMed ID: 16628080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosing colonopathy in cystic fibrosis: results of a case-control study.
    Kapadia C
    Gastroenterology; 1996 Jul; 111(1):260-1. PubMed ID: 8698212
    [No Abstract]   [Full Text] [Related]  

  • 19. Indomethacin and pancreatic enzymes synergistically damage intestine of rats.
    Kimura RE; Arango V; Lloyd-Still J
    Dig Dis Sci; 1998 Oct; 43(10):2322-32. PubMed ID: 9790472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrosing colonopathy in an adult owing to over use of pancreatic enzyme supplements.
    Bansi DS; Price A; Russell C; Sarner M
    Gut; 2000 Feb; 46(2):283-5. PubMed ID: 10644326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.